ATC code: L02AE02. Hormones and related agents. Gonadotrophin-releasing hormone analogues.

The product has been developed based on patented technology owned by GP Pharm.

Dosage: 22.5 mg

Dosage form: powder and solvent for extended-release injectable suspension

Format: 1 vial of 22.5 mg and 1 syringe of 2 ml

Therapeutic indications:

1. Palliative treatment of advanced hormone-dependent prostate cancer.

ATC code: L02AE02. Hormones and related agents. Gonadotrophin-releasing hormone analogues. 

The product has been developed based on patented technology owned by GP Pharm.

Dosage: 3.75 mg

Dosage form: powder and solvent for extended-release injectable suspension

Format: 1 vial and 2 ml pre-filled syringe

Therapeutic indications:

1. Palliative treatment of advanced hormone-dependent prostate cancer.

2. Uterine fibroids.

3. Endometriosis.

4. Advanced breast cancer in pre- and perimenopausal women.

5. Adjuvant in the treatment of early-stage hormone-sensitive breast cancer in pre- and perimenopausal women.

6. Ovarian protection in premenopausal women with neoplastic disease.

7. Central precocious puberty (CPP).

ATC code: H05AA02. Parathyroid hormones and analogues.

Dosage: 250 µg /ml (20 µg /80 ml)

Dosage form: solution for injection in pre-filled pen

Format: 1 pre-filled pen of 2.4 ml

Therapeutic indications:

1. Treatment of osteoporosis in postmenopausal women and in men with an increased risk of fracture.
2. Treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men with an increased risk of fracture.

ATC code: H01CC01. Hypothalamic hormones. Antigonadotrophin-releasing hormones. 

Dosage: 0,25 mg / 0,5 ml

Dosage form: solution for injection in a pre-filled syringe

Format: Box with 1 pre-filled syringe

              Box with 5 pre-filled syringes

Therapeutic indications:

1. Prevention of premature luteinizing hormone (LH) peaks in women undergoing controlled ovarian hyperstimulation (HOC) for assisted reproductive techniques (ART).

2. In clinical studies, ganirelix was used in conjunction with recombinant human follicle-stimulating hormone (FSH) or with corifolitropin alfa, a sustained follicular stimulant.

ATC code: H01BA02. Hormones from the posterior lobe of the pituitary gland. Vasopressin and analogues. 

Nictur® is the first oral Desmopressin solution on the market, which allows for easier administration, better adherence to treatment and greater patient comfort.

Dosage: 360 µg/ml

Dosage Form: Oral Solution

Size: 1 bottle with 15 ml

Therapeutic indications:

1. Treatment of central diabetes insipidus.
2. Treatment of primary nocturnal enuresis in patients older than 5 years with normal ability to concentrate urine.

ATC code: H01BB03. Hormones from the posterior lobe of the pituitary gland. Oxytocin and analogues. 

Carbetocin in pre-filled syringe. Ready to be administered to the patient.

Dosage: 100 μg

Dosage form: solution for injection in pre-filled syringe

Format: 5 pre-filled syringes of 1 ml

Therapeutic indications:

1. Prevention of postpartum haemorrhage (caesarean section or vaginal delivery) due to uterine atony.

ATC code: B06AC02. Other haematological agents. Drugs used in hereditary angioedema. 

Dosage: 30 mg

Dosage form: Injectable solution in a pre-filled syringe

Format: 1 pre-filled 3 ml syringe and 1 needle

Therapeutic indications:

1. Symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents and children over 2 years old, with C1 esterase inhibitor deficiency.

ATC code: H01CB02. Hypothalamic hormones. Somatostatin and analogues. 

Dosage: 

50 µg/ml

100 μg/ml

200 μg/ml

500 μg/ml

Dosage form: Injectable and infusion solution

 Format: 5 ampoules of 1 ml for doses of 50, 100 and 500 μg/ml

1 vial of 5 mL for the dose of 200 μg/mL

Therapeutic indications:

1. Treatment of patients with acromegaly.
2. Relief of symptoms associated with functional gastro-enteropancreatic endocrine tumors (GEPs).
3. Prevention of complications after pancreatic surgery.
4. Arresting bleeding caused by gastroesophageal varices in patients with cirrhosis.
5. Treatment of TSH-secreting pituitary adenomas.

ATC code: H01CB01. Hypothalamic hormones. Somatostatin and its analogues. 

Dosage: 3 mg

Dosage form: powder and solvent for solution for infusion

Format: 25 vials with lyophilized powder and 25 ampoules of solvent

Therapeutic indications:

1. Treatment of gastrointestinal bleeding due to the rupture of esophageal varices.
2. Adjuvant in the treatment of secretory pancreatic fistulas of at least 500 ml/day.